A new trading day began on Tuesday, with Elanco Animal Health Inc (NYSE: ELAN) stock price up 0.90% from the previous day of trading, before settling in for the closing price of $20.04. ELAN’s price has ranged from $8.02 to $21.76 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 29.95% over the past five years. Meanwhile, its annual earnings per share averaged -1.65%. With a float of $492.01 million, this company’s outstanding shares have now reached $496.65 million.
Let’s look at the performance matrix of the company that is accounted for 9450 employees.
Elanco Animal Health Inc (ELAN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Elanco Animal Health Inc is 0.97%, while institutional ownership is 108.56%. The most recent insider transaction that took place on Aug 11 ’25, was worth 830,000. Before that another transaction happened on Mar 07 ’25, when Company’s Director bought 10,000 for $10.90, making the entire transaction worth $109,000. This insider now owns 101,459 shares in total.
Elanco Animal Health Inc (ELAN) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.13 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.80% during the next five years compared to 29.95% growth over the previous five years of trading.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Here are Elanco Animal Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.24. Likewise, its price to free cash flow for the trailing twelve months is 27.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.87, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 1.00 in one year’s time.
